3
Announcements
Trials
Browse
Landscape
Status
Unknown
2
Completed
2
Terminated
1
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Lung Neoplasms
4
Head and Neck Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Breast Neoplasms
4
Glioblastoma
3
Colorectal Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
2
Pancreatic Neoplasms
2
Leukemia, Myeloid, Acute
2
Leukemia
2
Glioma
2
Endometrial Neoplasms
2
Carcinoma, Squamous Cell
2
Carcinoma, Hepatocellular
2
Brain Neoplasms
2
Uterine Cervical Neoplasms
1
Urologic Neoplasms
1
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Solid Tumor
1
Small Cell Lung Carcinoma
1
Sezary Syndrome
1
Sarcoma
1
Rhabdoid Tumor
1
Renal Insufficiency
1
Recurrence
1
Prostatic Neoplasms
1
Precancerous Conditions
1
Postoperative Complications
1
Pancreatic carcinoma, familial
1
Interventions
Cyclophosphamide
6
fludarabine
5
toripalimab
3
Paclitaxel
3
Etoposide
3
Carboplatin
3
Bevacizumab
3
zimberelimab
2
tislelizumab
2
sintilimab
2
glumetinib
2
Vincristine
2
Temozolomide
2
Platinum
2
Immune Checkpoint Inhibitors
2
Hepatectomy
2
Gemcitabine
2
Drug Therapy
2
Docetaxel
2
Cisplatin
2
Capecitabine
2
venetoclax
1
relmacabtagene autoleucel
1
osimertinib
1
lenvatinib
1
irinotecan sucrosofate
1
glofitamab
1
gallium maltolate
1
fludarabine phosphate
1
eribulin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Recurrence
×
Blood Specimen Collection
×
Clear all
NCT07570407
2026-05-06
QiNKT-HSCT
University Hospital Pilsen
Not yet recruiting
75 enrolled